Lynley K. Lewis
Christchurch, CAN, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The Family Heart Study: rationale, design and methodology.
Journal: The New Zealand medical journal
Published: July 30, 2026
Lower NT-proBNP plasma concentrations in Pacific peoples with heart failure.
Journal: ESC heart failure
Published: December 14, 2024
Metabolism of Natriuretic peptides and impact on insulin resistance and fat mass in healthy subjects.
Journal: Clinical biochemistry
Published: October 17, 2024
Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspnea.
Journal: Frontiers in cardiovascular medicine
Published: June 06, 2023
Assays Specific for BNP1-32 and NT-proBNP Exhibit a Similar Performance to Two Widely Used Assays in the Diagnosis of Heart Failure.
Journal: Clinical chemistry
Published: April 06, 2022
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations.
Journal: EBioMedicine
Published: February 23, 2022
Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals.
Journal: Scientific reports
Published: September 08, 2020
ProBNP processing is decreased by obesity in patients with heart failure.
Journal: Annals of translational medicine
Published: March 17, 2020
Circulating Forms of B-Type Natriuretic Peptide in Very Preterm Infants.
Journal: The journal of applied laboratory medicine
Published: May 12, 2019
ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.
Journal: Clinical chemistry
Published: February 04, 2019
Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNP.
Journal: Clinical chemistry
Published: November 28, 2016
Last Updated: 09/26/2026